Description
This option includes an urgent care provider evaluation for patients seeking treatment related to eyelash growth concerns. Latisse (bimatoprost 0.03%) is a prescription solution applied to the base of the upper eyelashes. It is FDA-approved to treat eyelash hypotrichosis (too few or short lashes). A licensed provider reviews the patient’s medical history, eye health history, and questionnaire responses to determine whether treatment may be appropriate. If approved, medication is prescribed in accordance with clinical guidelines. Treatment is not guaranteed and is subject to provider discretion.
Reviews
There are no reviews yet.